Joseph B. Wetter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Joseph B. Wetter has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Katherine M. Salte
AbbVie Inc North Chicago IL USA
4 shared publications - Prisca Honore
AbbVie Inc North Chicago IL USA
4 shared publications - Kathleen M. Smith
AbbVie Inc., North Chicago, USA
3 shared publications - Stephen B. Gauld
Pediatrics, Medical College of Wisconsin , Milwaukee, WI
3 shared publications - Viktor Todorović
Abbvie Inc North Chicago Illinois USA
3 shared publications - Donna Gauvin
Dermatology, AbbVie Inc, North Chicago, Illinois, USA
2 shared publications
Latest Publications
- 1 July 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 141 (7) , 1772-1779.e6
ACT1 Is Required for Murine IL-23–Induced Psoriasiform Inflammation Potentially Independent of E3 Ligase Activity
- 1 July 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 141 (7) , 1772-1779.e6
ACT1 Is Required for Murine IL-23–Induced Psoriasiform Inflammation Potentially Independent of E3 Ligase Activity
- 15 June 2021
- Published by Wiley in Experimental Dermatology
- Vol. 30 (6)
Cover Image
- Open Access
- 30 December 2020
- Published by Wiley in Experimental Dermatology
- Vol. 30 (6) , 820-830
Histologic progression of acne inversa/hidradenitis suppurativa: Implications for future investigations and therapeutic intervention
Since first recognized in 1839, the pathogenesis of acne inversa (AI) has undergone repeated revisions. Although there is agreement that AI involves occlusion of hair follicles with subsequent inflammation and the formation of tracts, the histologic progression of this disease still requires refinement. The objective of this study was to examine the histologic progression of AI based on the examination of a large cohort of punch biopsies and excisional samples that were examined first by hematoxylin and eosin staining. The most informative of these samples were step‐sectioned and stained by immunohistochemistry for epithelial and inflammatory markers. Based on this examination, the following observations were made: 1) AI arises from the epithelium of the infundibulum of terminal and vellus hairs; 2) These form cysts and epithelial tendrils that extend into soft tissue; 3) Immunohistochemical staining demonstrates the epithelium of AI is disordered with infundibular and isthmic differentiation and de novo expression of stem cell markers; 4) The inflammatory response in AI is heterogeneous and largely due to cyst rupture. The conclusions of this investigation were that AI is an epithelial‐driven disease caused by infiltrative, cyst forming tendrils and most of the inflammation is due to cyst rupture and release of cornified debris and bacteria. Cyst rupture often occurs below the depths of punch biopsy samples indicating their use for analysis may give an incomplete picture of the disease. Finally, our data suggest that unless therapies inhibit tendril development, it is unlikely they will cause prolonged treatment‐induced remission in AI.
- 30 December 2020
- Published by Wiley in Experimental Dermatology
- Vol. 30 (6) , 820-830
Open AccessHistologic progression of acne inversa/hidradenitis suppurativa: Implications for future investigations and therapeutic intervention
Since first recognized in 1839, the pathogenesis of acne inversa (AI) has undergone repeated revisions. Although there is agreement that AI involves occlusion of hair follicles with subsequent inflammation and the formation of tracts, the histologic progression of this disease still requires refinement. The objective of this study was to examine the histologic progression of AI based on the examination of a large cohort of punch biopsies and excisional samples that were examined first by hematoxylin and eosin staining. The most informative of these samples were step‐sectioned and stained by immunohistochemistry for epithelial and inflammatory markers. Based on this examination, the following observations were made: 1) AI arises from the epithelium of the infundibulum of terminal and vellus hairs; 2) These form cysts and epithelial tendrils that extend into soft tissue; 3) Immunohistochemical staining demonstrates the epithelium of AI is disordered with infundibular and isthmic differentiation and de novo expression of stem cell markers; 4) The inflammatory response in AI is heterogeneous and largely due to cyst rupture. The conclusions of this investigation were that AI is an epithelial‐driven disease caused by infiltrative, cyst forming tendrils and most of the inflammation is due to cyst rupture and release of cornified debris and bacteria. Cyst rupture often occurs below the depths of punch biopsy samples indicating their use for analysis may give an incomplete picture of the disease. Finally, our data suggest that unless therapies inhibit tendril development, it is unlikely they will cause prolonged treatment‐induced remission in AI.
- 1 May 2020
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 140 (5) , 1015-1025.e4
Persistence of Inflammatory Phenotype in Residual Psoriatic Plaques in Patients on Effective Biologic Therapy
- 1 May 2020
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 140 (5) , 1015-1025.e4
Persistence of Inflammatory Phenotype in Residual Psoriatic Plaques in Patients on Effective Biologic Therapy
- Open Access
- 1 October 2018
- Published by Elsevier in Journal of Dermatological Science
- Vol. 92 (1) , 45-53
Mechanistic and pharmacological assessment of murine IL-23 mediated psoriasiform dermatitis; implications for drug discovery
- 1 October 2018
- Published by Elsevier in Journal of Dermatological Science
- Vol. 92 (1) , 45-53
Open AccessMechanistic and pharmacological assessment of murine IL-23 mediated psoriasiform dermatitis; implications for drug discovery
- 1 May 2016
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 136 (5) , S94
534 Defining a mechanistic link between TRPV3 activity and psoriasis through IL-1α and EGFR signaling pathways
- 1 May 2016
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 136 (5) , S94
534 Defining a mechanistic link between TRPV3 activity and psoriasis through IL-1α and EGFR signaling pathways